Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by National Bank of Canada FI

National Bank of Canada FI grew its holdings in Hims & Hers Health, Inc. (NYSE:HIMS) by 438.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,990 shares of the company’s stock after purchasing an additional 2,435 shares during the quarter. National Bank of Canada FI’s holdings in Hims & Hers Health were worth $72,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Means Investment CO. Inc. lifted its stake in Hims & Hers Health by 23.5% in the 4th quarter. Means Investment CO. Inc. now owns 50,040 shares of the company’s stock valued at $1,210,000 after buying an additional 9,508 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Hims & Hers Health by 102.0% in the third quarter. Principal Financial Group Inc. now owns 290,414 shares of the company’s stock worth $5,349,000 after acquiring an additional 146,621 shares during the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of Hims & Hers Health in the fourth quarter valued at $2,628,000. Pacer Advisors Inc. acquired a new stake in shares of Hims & Hers Health during the fourth quarter valued at $374,000. Finally, Genesee Capital Advisors LLC purchased a new stake in Hims & Hers Health during the 4th quarter worth about $889,000. 63.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Hims & Hers Health

In related news, insider Soleil Boughton sold 4,152 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $60.69, for a total transaction of $251,984.88. Following the sale, the insider now directly owns 157,345 shares in the company, valued at approximately $9,549,268.05. This trade represents a 2.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Irene Becklund sold 2,203 shares of the company’s stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $28.78, for a total value of $63,402.34. Following the completion of the transaction, the insider now owns 8,007 shares of the company’s stock, valued at approximately $230,441.46. This represents a 21.58 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 835,884 shares of company stock worth $31,659,701. 17.71% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on HIMS shares. BTIG Research started coverage on shares of Hims & Hers Health in a report on Tuesday, January 7th. They issued a “buy” rating and a $35.00 target price on the stock. Leerink Partners upped their price objective on shares of Hims & Hers Health from $24.00 to $40.00 and gave the company a “market perform” rating in a research note on Tuesday, February 25th. Piper Sandler lifted their target price on shares of Hims & Hers Health from $24.00 to $35.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 25th. Morgan Stanley lowered Hims & Hers Health from an “overweight” rating to an “equal weight” rating and increased their price target for the stock from $42.00 to $60.00 in a research note on Tuesday, February 18th. Finally, Canaccord Genuity Group raised their price objective on Hims & Hers Health from $38.00 to $68.00 and gave the stock a “buy” rating in a report on Wednesday, February 19th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $38.25.

Hims & Hers Health Price Performance

Shares of NYSE:HIMS opened at $27.13 on Friday. The business has a 50-day moving average of $38.75 and a two-hundred day moving average of $30.37. The firm has a market capitalization of $6.03 billion, a PE ratio of 61.66 and a beta of 1.65. Hims & Hers Health, Inc. has a 12 month low of $11.20 and a 12 month high of $72.98.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The firm had revenue of $481.14 million during the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. As a group, research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.